Shearman & Sterling advised Boston Scientific Corporation, as Borrower on a $1 billion unsecured 364-day term loan facility agented by The Bank of Nova Scotia to repay the amounts outstanding under its existing term loan credit agreement and to pay transaction costs related to such repayment.

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular.

The Team